Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition. [electronic resource]
- Cancer discovery 09 2017
- 1006-1017 p. digital
Antineoplastic Agents--therapeutic use Cell-Free Nucleic Acids--blood Gene Frequency Humans Male Mutation Phthalazines--therapeutic use Piperazines--therapeutic use Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use Prognosis Prostatic Neoplasms--blood Exome Sequencing